Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | XL147 |
Trade Name | |
Synonyms | SAR245408|Pilaralisib|XL-147 |
Drug Descriptions |
Pilaralisib (XL147) is an inhibitor of all class I PI3Ks, thereby blocking activation of the PI3K signaling pathway and potentially resulting in antitumor activity including inhibition of cell proliferation, cell invasion, and tumor growth (PMID: 25637314, PMID: 29593099). |
DrugClasses | PI3K Inhibitor (Pan) 42 |
CAS Registry Number | 934526-89-3 |
NCIT ID | C71705 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Paclitaxel + XL147 | Carboplatin Paclitaxel XL147 | 0 | 0 |
Carboplatin + XL147 | Carboplatin XL147 | 0 | 0 |
Paclitaxel + XL147 | Paclitaxel XL147 | 1 | 0 |
Seribantumab + XL147 | Seribantumab XL147 | 0 | 0 |
Trastuzumab + XL147 | Trastuzumab XL147 | 0 | 0 |
Voxtalisib + XL147 | Voxtalisib XL147 | 0 | 0 |
XL147 | XL147 | 9 | 1 |